Table 2. Patient demographics of all Fenestrated endovascular aneurysm repair (F-EVAR) case series included.
References | Type of study | Patients | Sex (M/F) | Age | Major Comorbidities | Aneurysm diameter (mm) | Length of aneurysm neck (mm) | Treatment period | Country |
---|---|---|---|---|---|---|---|---|---|
Lee et al. 201438 | Single arm | 15 | 10:5 | 77.4 | 11 smokers; 12 CAD; 7 CHF; 14 HTN; | 61.6 (47–105) | 4.5 (2–8) | 2012–2013 | U.S. |
2 COPD; 3 DM; 1 Prior AAA repair; | |||||||||
Globalstar. 201218 | Single arm | 318 | 274:44 | 74 (47–86) | 44 DM; 196 HTN; 149 CAD; 19 CHF; | 65 (46–112) | N.D. | 2007.1–2010.12 | U.K. |
44 Renal Failure; 27 CVD; | |||||||||
3 Previous aortic surgery; | |||||||||
Liao et al. 201439 | Single arms | 8 | 4:4 | 75 (64–85) | 3 CAD; 5 COPD | 58 (52–63) | 6 (4–12) | 2012.8–2013.5 | U.S. |
Dijkstra et al. 201440 | Single arm | 25 | 22:3 | 73 ± 7.1 | 3 DM; 15 HTN; 9 Hyperlipidemia; | 61 (55–88) | N.D. | 2011.5–2013.9 | Duth |
9 smoker; 18 cardiac; 8 renal disease; | |||||||||
3 pulmonary disease; | |||||||||
Donas et al. 201231 | 2 arms | 29 | 29:0 | 73.7 ± 6.1 | 24 cardiac; 5 RI; 11 respiratory; 7 MI; | 65 | N.D. | 2008.1–2010.12 | Germany |
8 previous aortic intervention; | |||||||||
12 aortocoronary surgery; | |||||||||
Suominen et al. 201332 | 2 arms | 21 | 21:0 | 73 | 4 DM; 9 hyperlipidemia; 13 HTN; 14 CAD; 6 respiratory disease; 19 renal failure; | 65 ± 7 | 2.5 (0–2.5) | 2007.12–2011.8 | Finland |
4 smokers; | |||||||||
Greenberg et al. 200941 | Single arm | 30 | 24:6 | 75 (59–86) | 8 MI; 3 CHF; 15 CAD; 14 arrhythmia; | 61.4 ± 9.7 (48.8–88) | 9.2 ± 2.9 (2.4–14.4) | 2005.1–2006.1 | Global |
26 HTN; 5 thromboembolic event; 7 PAD; | |||||||||
9 COPD; 2 RI; 7 DM; 5 CVD; 27 smokers; | |||||||||
Tambyraja et al. 201142 | Single arm | 29 | 27:2 | 74 (54–86) | 21 smoker/COPD; 15 HTN; 13 MI; 3 CRF ; | 68 ± 7 | N.D. | 2005.10–2010.3 | U.K. |
4 hostile abdomen;;2 CVD; 3 cardic failure | |||||||||
Oderich et al. 201443 | Single arm | 67 | 54:13 | 74 ± 8 | 60 HTN; 59 smokers; 36 CAD; 20 MI; | 60 ± 10 (47–100) | 7.5 ± 2.3 (4–12) | 2005–2012 | U.S. |
21 Arrhythmia; 24 COPD; 16 CKD; 16 DM; 15 PAD; 11 CVD; 7 CHF; | |||||||||
7 history of thromboembolic event; |
N.D. not documented; CAD, coronary artery disease; RI, renal impairment; MI, myocardial infarction arrhythmia; DM, diabetes mellitus; HTN, hypertension; CHF, congestive heart failure; PAD, peripheral arterial disease; CVD, cerebrovascular disease; CRF, Chronic renal failure; CKD, Chronic kidney disease.